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Citrus aurantium peel extract
Hepatic ﬁbrosisABSTRACT
Objective: To evaluate the possible protective effect of Citrus aurantium peel extract
(CAE) against apoptosis in cholestatic liver ﬁbrosis induced by bile duct ligation in mice.
Methods: Male ICR mice were divided to 5 groups: 1) Control group (Sham-operated
mice), 2) Cholestatic liver injury group induced by bile duct ligation (BDL), 3) BDL mice
treated with silymarin (200 mg/kg) for 4 weeks, 4) BDL mice treated with 50 mg/kg CAE
for 4 weeks, 5) BDL mice treated with 200 mg/kg CAE for 4 weeks. Mice were sacriﬁced
and liver ﬁbrosis was evaluated by serum and hepatic tissue biochemistry tests and liver
histopathological examination. Effects of CAE on inﬂammation and apoptosis gene
regulation were investigated through real-time PCR. CAE effect on lipid metabolism
related signaling was determined by western blot analysis.
Results: In BDL mice, administration of CAE for 4 weeks markedly attenuated liver
ﬁbrosis based on histopathological alteration. Serum and hepatic tissue biochemistry
results revealed that CAE (50 and 200 mg/kg) decreased the levels of alanine trans-
aminase, aspartate transaminase, gamma-glutamyl transferase, total bilirubin, nitric oxide,
and thiobarbituric acid reactive substances. Real-time PCR and western blot analysis
showed that CAE regulated inﬂammation, apoptosis, and lipid metabolism factors
increased by BDL. Interleukin family, tumor necrosis factor a, and related apoptosis
factors mRNA levels were increased by BDL treatment. However, these increases were
suppressed by CAE administration. In addition, CAE effectively increased phosphory-
lation of AMP-activated protein kinase, nuclear factor E2-related factor 2, and related
cytoprotective proteins.
Conclusions: CAE can efﬁciently regulate BDL-induced liver injury with antioxidant,
anti-inﬂammatory, and anti-apoptotic activities.1. Introduction
The pathogenesis of cholestatic liver injury caused by bile
duct obstruction or functional defect in bile formation is thought
to have a critical role in extra-hepatic damage [1]. Stagnant bile
acid causes hepatotoxicity, disrupts hepatocyte cell membranes,
and releases reactive oxygen species from peritoneal neutrophil
in cholestatic liver diseases with lipid peroxidation [2,3]. Intra-
hepatic accumulation of bile acid and toxic materials causes
pro-inﬂammation and oxidative stress, leading to ﬁbrosis and
cirrhosis [4].
Surgical bile duct ligation (BDL) experimental model has
been well characterized to conﬁrm obstructive cholestatic livericle under the CC BY-NC-ND license (http://
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represented by inﬂammation, ﬁbrosis, cirrhosis, and eventually
hepatocellular apoptosis progresses insidiously, resulting in
histopathological symptom as in human cholestasis [5,6].
Citrus has abundant polymethoxy ﬂavones. Nobiletin is a
relatively common polymethoxy ﬂavonoid (PMF) compound
present in the peel of citrus [7]. Six methoxyl groups on the base
structure of ﬂavone of nobiletin have been intensively studied
due to their biological properties [8]. It has been reported that
nobiletin is metabolized and bio-transformed to metabolites
with different activities, such as regulating adipogenesis,
inﬂammation, and carcinogenesis [9,10].
Our previous studies have found that a polymethoxy
ﬂavonoids-rich Citrus aurantium peel extract (CAE) containing
approximately 27% of nobiletin has hepatoprotective effects on
binge drinking and carbon tetrachloride intoxication in mouse
models [11,12]. However, the effect of CAE as an anti-cholestasis
material remains unclear. Therefore, we used CAE, the same
material used in previous in vivo studies, to investigate its potential
effects on liver injury. Speciﬁcally, the objective of this study was
to determine the possible protective effect of CAE against
cholestatic liver ﬁbrosis induced by BDL in mouse model.
2. Materials and methods
2.1. Chemicals and reagents
Nobiletin standard compound was purchased from Sigma–
Aldrich (MO, USA). Assay kits for superoxide dismutase (SOD),
thiobarbituric acid reactive substances (TBARS), and glutathione
(GSH) were obtained from Cayman Chemical Company (MI,
USA). Assay kit for nitric oxide (NO) was purchased from
BioAssay Systems (CA, USA). Protein assay reagent and poly-
vinylidene diﬂuoride membranes were purchased from Bio-Rad
Laboratories (CA, USA). The following antibodies were pur-
chased from Santa Cruz Biotechnology (CA, USA): anti-nuclear
factor erythroid 2-related factor 2 (Nrf-2, sc-722), NAD(P)H:
Quinone oxidoreductase-1 (NQO-1, sc-376023), Uridine 50-
diphospho-glucuronosyltransferase (UGT, sc-25847), g-gluta-
mylcysteine synthetase (g-GCS, sc-28965), b-actin (sc-3700),
AMP-activated protein kinase a (AMPKa, sc-25792), and
phospho-AMPK (p-AMPKa, sc-33524). All other reagents were
purchased from Sigma Chemicals (MO, USA).
2.2. CAE preparation
Ethanol extract of Citrus aurantium peel was supplied by
KPLC group (Paris, France) and prepared as described previ-
ously [11,12]. The main ﬂavonoid constituent in CAE was
analyzed by high performance liquid chromatography.
Chromatographic analysis was performed according to the
method of Choi et al. (2015).
2.3. Animal treatment
Male ICR mice (5–6) weeks old were obtained from Orient
Bio (Sungnam, Korea) and housed in animal facility of Chung-
namNational University. Mice were ad libitum fed with lab chow
and water under stable condition of (22 ± 2) C, 55% ± 5% hu-
midity, and 12 h light/dark cycle. After acclimation, mice were
randomly divided into 5 groups: 1) control group, 2) BDL alonegroup, 3) BDL + silymarin (200 mg/kg) group, 4) BDL + CAE
(50 mg/kg) group, and 5) BDL + CAE (200 mg/kg) group. In all
BDL groups, the common bile duct was identiﬁed by laparotomy,
doubly ligated using 6–0 nylon sutures, and transected. After
24 h, all mice were given respective drugs for 4 weeks. Mice in
the control group and BDL alone group were treated with distilled
water. At the end of the 4-week treatment, mice were killed by
cardiac puncture under carbon dioxide anesthesia. Serum and
liver samples were collected and stored for further analyses.
Tissues for histopathological study were ﬁxed in neutral buffered
formalin. All animal experiments were approved by the Institu-
tional Animal Care and Use Committee of the Institute of
Chungnam National University (Daejeon, Korea, CNU-00374).
2.4. Serum biochemical examination
Serum levels of alanine aminotransferase (ALT), aspartate
aminotransferase (AST), gamma-glutamyl transferase (GGT),
total bilirubin (TBIL), and total cholesterol (TCHO) were
analyzed using a dry chemistry system (FUJI DRI-CHEM
4000i, Fuji Medical System, Tokyo, Japan).
2.5. Liver histopathology
Parafﬁn embedded liver tissues were sectioned at thickness of
5 mm and stained with hematoxylin and eosin (H&E), Masson's
trichrome (MT), and Sirius red. Liver injury was scored in H&E
stained tissue using a scale of 0–5 (0, none; 1, <10%; 2, 10%–
25%; 3, 25%–50%; 4, 50%–70%; and 5, >75%) depending on
the percentage of damaged area. Fibrosis score was determined
for Masson's trichrome stained sections by using modiﬁed Ishak
system as follows: 0, no ﬁbrosis; 1, ﬁbrous expansion of portal
tracts, without short ﬁbrous septa; 2, ﬁbrous expansion with
short ﬁbrous septa; 3, portal to portal ﬁbrous bridging; 4, portal
to portal and portal to central ﬁbrous bridging; 5, cirrhosis [13].
Collagen deposition in Sirius red-positive stained area was
quantiﬁed using Image J software (National Institutes of Health,
Bethesda, MD, USA).
2.6. Liver tissue biochemistry
The contents of glutathione (GSH), superoxide dismutase
(SOD), nitric oxide (NO), and thiobarbituric acid reactive sub-
stances (TBARS) in liver tissues were determined using com-
mercial kits from BioAssay Systems (CA, USA) according to
the manufacturer's instructions.
2.7. Western blot analysis
Liver tissue was homogenized with radioimmunoprecipitation
assay (RIPA) buffer containing protease inhibitor cocktail and
centrifuged at 15000 ×g for 15 min at 4 C. Supernatants were
collected and subjected to protein assay. Adequate proteins were
separated by 10% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and transferred to polyvinylidene
diﬂuoride membranes followed by blocking with 5% of nonfat
dried skim milk. After blocking, membranes were incubated with
primary antibodies. After washing, membranes were incubated
with horseradish peroxidase-conjugated secondary antibodies.
Immunoreactive bands were visualized with Chemiluminometer
(CLINX Science Instruments, Shanghai, China).
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Liver total RNA was extracted using TRIzol reagent (Invi-
trogen, Carlsbad, CA, USA). For cDNA synthesis, oligo dT
primers (1 mL, 0.5 pmole; Promega, WI, USA) were added to the
reaction in a total volume of 9 mL. After denaturing at 70 C for
5min, themixturewas immediately cooled down at 4 C for 5min.
The following componentswere then added to themixture:MgCl2
(4 mL of 25 mM), 5× reverse transcriptase enzyme buffer (4 mL),
RNase inhibitor (1 mL), reverse transcriptase (1 mL), and dNTPs
(1 mL, 10 mM). After gentle vortexing, the mixture was then
incubated at 25 C for 5 min, 42 C for 60 min, and 70 C for
15 min. SYBR Green-based real-time PCR was performed using
SensiMix Plus SYBR (Quantace, London, UK) based on the
manufacturer's protocol. PCR was performed using primers spe-
ciﬁc for Interleukin (IL) family genes, tumor necrosis factor a
(TNF a), and apoptosis related genes as follows: IL-2, CCC ACT
TCA AGC TCC ACT TC and ATC CTG GGG AGT TTC AGG
TT; IL-4, TCA ACC CCC AGC TAG TTG TC and TGT TCT
TCG CTG TGA GG; IL-6, AGC CCC CAG TCT GTA TCC TT
and TCC ACG ATT TCC CAG AGA AC; TNF a, AGC CCC
CAG TCT GTA TCC TT and CTC CCT TTG CAG AAC TCA
GG; FAS, CCC TTG ATG AAG AGG GAT CA and ACT CCA
CAG GTG GGA ACA AG; Tumor necrosis factor-related
apoptosis-inducing ligand (TRAIL), GAA GAC CTC AGA
AAGTGGC and GACCAGCTC TCCATTCCTA; Caspase-8,
CCA GGA AAA GAT TTG TGT CTA GC and GGC CTT CCT
GAG TAC TGT CAC CTG T. Real-time PCR was carried out on
Roto-Gene 6000 (Corbett, Mortlake, AUS) with gradient sched-
ules as follows: 10min at 95 C and 40 cycles of 95 C (5 s), 60 C
(15 s), and 72 C (25 s). The expression levels of mRNAs were
normalized against the level of glyceraldehyde-3-phosphatede-
hydrogenase (GAPDH). Results were analyzed using the
comparative cycle threshold method [14].
2.9. Statistical analysis
All data were expressed as mean ± SEM. Signiﬁcance dif-
ferences between experimental groups were determined using
analysis of variance (ANOVA) with Tukey's test or Mann–
Whitney U-test using the software, Origin 7 (Microcal Software,
USA). Statistical signiﬁcance was considered when P value was
less than 0.05.
3. Results
3.1. Effect of CAE on serum proﬁles of BDL mice
Bile duct ligation caused severe hepatocellular injury. To
assess the effect of CAE on liver physiology, serum levels ofTable 1
Effect of Citrus aurantium extract on serum proﬁles in bile duct-ligated mou
Group ALT (U/L) AST (U/L
Control 23.0 ± 1.4 84.8 ± 4.8
BDL alone 507.7 ± 57.5# 604.0 ± 65.5
BDL + silymarin (200 mg/kg) 375.2 ± 52.6* 452.2 ± 116
BDL + CAE (50 mg/kg) 320.2 ± 33.1 418.6 ± 16.2
BDL + CAE (200 mg/kg) 310.4 ± 48.8* 391.6 ± 52.3
#P < 0.05 compared with control group.
*P < 0.05 compared with BDL alone group.ALT and AST were measured. As expected, ALT and AST
levels were signiﬁcantly (P < 0.05) increased (22-fold and 7-
fold, respectively) in BDL group compared to those of control
group without BDL (Table 1). The administration of CAE (50
and 200 mg/kg) to BDL mice for 4 weeks reduced the increases
of serum ALT and AST levels caused by BDL. Serum levels of
ALT and AST of the treatment group with high dose CAE
(200 mg/kg) were signiﬁcantly (P < 0.05) decreased (reduced
38.9% and 35.2%, respectively) compared with BDL alone.
They were decreased even more compared to the levels in the
group treated with silymarin. Serum concentrations of GGT,
TCHO, and TBIL indicating biliary cell damage and cholestasis
caused by BDL are shown in Table 1. Serum levels of GGT,
TCHO, and TBIL in BDL alone group were signiﬁcantly
(P < 0.05) higher compared to those in the control group. In
BDL mice treated with CAE (200 mg/kg), serum levels of GGT,
TCHO, and TBIL were signiﬁcantly (P < 0.05) reduced (by
38.4%, 27.0%, and 18.2%, respectively) compared to those of
the control group.
3.2. Effect of CAE on levels of antioxidants in BDL mice
Enhanced oxidative status is associated with liver ﬁbrosis.
The oxidative status of the liver in BDL-induced mouse model
was evaluated by measuring the levels of GSH, SOD, TBARS,
and NO in the liver (Figure 1). The levels of GSH and SOD
showed marked (P < 0.05) reduction in the BDL group compare
to those of the control group. However, administration of CAE
(50 and 200 mg/kg) recovered GSH and SOD levels. Treatment
with CAE 200 mg/kg signiﬁcantly (P < 0.05) increased their
levels compared to BDL group alone. Levels of TBARS were
monitored to determine lipid peroxidation levels. TBARS levels
in BDL group were signiﬁcantly (P < 0.05) higher than that of
the normal control group. Administration with CAE adminis-
tration to BDL treated mice decreased the increase of hepatic
TBARS concentration in a dose-dependent manner. The levels
of NO were also signiﬁcantly (P < 0.05) reduced in the group
treated with 200 mg/kg of CAE compared to that of the BDL
group without CAE treatment.
3.3. Effect of CAE on mRNA levels in BDL mouse model
To investigate whether CAE has anti-inﬂammatory or anti-
apoptosis effects, the mRNA expression levels of pro-
inﬂammatory cytokines and tumor necrosis factor-related
apoptosis genes in liver tissues were determined by quantita-
tive real-time PCR. As shown in Figure 2A, mRNA expression
levels of interleukins and TNF a in BDL mice treated with CAE
(50 and 200 mg/kg) were signiﬁcantly (P < 0.05) decreased in a
dose-dependent manner compared to those in BDL alone group.se model.
) GGT (U/L) TCHO (mg/dL) TBIL (mg/dL)
11.1 ± 3.8 139.0 ± 8.3 1.1 ± 0.2
# 31.5 ± 3.5# 239.7 ± 25.3# 17.9 ± 1.8#
.2* 22.5 ± 2.3* 134.1 ± 6.9* 15.5 ± 1.1#
32.6 ± 3.4 296.0 ± 20.7 18.1 ± 2.2#
* 19.4 ± 2.3* 174.8 ± 13.5* 14.6 ± 1.6#
Figure 1. Effect of Citrus aurantium extract on liver oxidative states of BDL mice. At 24 h after BDL operation, mice were orally administered with
distilled water, silymarin (200 mg/kg), or CAE (50 or 200 mg/kg) daily for 4 weeks. Levels of glutathione (GSH) (A), superoxide dismutase (SOD) (B),
nitric oxide (NO) (C), and thiobarbituric acid reactive substances (TBARS) (D) in the liver tissue were determined. #P < 0.05 compared with control group;
*P < 0.05 compared with BDL alone group.
Figure 2. Effect of CAE on inﬂammation (A) and apoptosis (B) related signals in the livers of BDL mice. At 24 h after BDL operation, mice were orally
administered with distilled water, silymarin (200 mg/kg), or CAE (50 or 200 mg/kg) daily for 4 weeks. Total RNA was extracted from liver tissues and
cytokines expression levels were quantiﬁed by SYBR Green-based real-time PCR using mouse-speciﬁc cytokine primers. *P < 0.05 compared with BDL
alone group.
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with CAE are shown in Figure 2B. The mRNA levels of
apoptosis related genes such as FAS, TRAIL, and Caspase-8
were signiﬁcantly (P < 0.05) decreased in BDL mice treated
with CAE (50 and 200 mg/kg) compared to those in BDL alone
group.
3.4. Effect of CAE on histopathological alteration in
BDL mice
Four weeks after CAE administration to BDL mice, liver
histological changes were observed. Results are shown in
Figure 3. After liver tissues were stained with hematoxylin and
eosin and compared to those of the control group, BDL caused
dissociation and lytic necrosis of hepatocytes. The necrosis andneutrophilic inﬁltration observed in the BDL alone group were
reduced in BDL mice treated with CAE. Based on Ishak's score
of statistical analysis, the pathologic alteration score of the BDL
alone group was signiﬁcantly (P < 0.05) increased compared to
that of the normal control group. However, treatment with CAE
signiﬁcantly (P < 0.05) decreased the injury score compared to
BDL alone.
Liver ﬁbrosis and collagen depositions in liver tissues induced
by BDL were determined by MT staining and Sirius red staining,
respectively (Figure 3B and C). The control group showed
normal lobular architecture with central veins. However, the BDL
group showed markedly (P < 0.05) widespread destruction of
liver architecture with increased connective tissue, extensive
collagen deposition, pseudolobular formation, and ﬁbrosis.
Treatment with CAE (50 and 200 mg/kg) signiﬁcantly (P < 0.05)
Figure 3. Effect of CAE on pathological changes in the livers of BDL mice. At 24 h after BDL operation, mice were orally administered with distilled
water, silymarin (200 mg/kg), or CAE (50 or 200 mg/kg) daily for 4 weeks. Representative photomicrographs of liver sections were processed for he-
matoxylin & eosin (H&E) staining (A), Masson's trichrome staining (B), and Sirius red staining (C). Bar: 100 mm. #P < 0.05 compared with the control
group; *P < 0.05 compared with BDL alone group.
Figure 4. Effect of CAE on protein expression in the livers of BDL mice. At 24 h after BDL operation, mice were orally administered with distilled water,
silymarin (200 mg/kg), or CAE (50 or 200 mg/kg) daily for 4 weeks. Levels of phospho-AMPKa (A) and Nrf2 related signals (B) were assessed by western
blot analysis. Levels of AMP-activated protein kinase (AMPK), nuclear factor E2-related factor 2 (Nrf2), NAD (P) H: Quinone oxidoreductase-1 (NQO-1),
g-glutamylcysteine synthetase heavy subunit (gGCSc), and Uridine 5’-diphospho-glucuronosyltransferase (UGT) were measured. *P < 0.05 compared with
BDL alone group.
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had a normal distribution of collagen. However, collagen depo-
sition was increased in the BDL alone group. On the other hand,
CAE treatment (200 mg/kg) signiﬁcantly (P < 0.05) reduced
collagen deposition compared to BDL alone group.
3.5. Effect of CAE on AMPK and Nrf-2 related protein
expression in BDL mice
The effect of CAE on BDL-induced AMPK and Nrf-2 related
protein levels in liver tissues were investigated by western
blotting. As shown in Figure 4, administration with CAE (50
and 200 mg/kg) signiﬁcantly (P < 0.05) enhanced p-AMPK
expression levels compared to BDL alone group (Figure 4A).
The expression levels of Nrf2, NQO1, gGCSc, and UGT in the
BDL alone group were markedly (P < 0.05) decreased
compared to those in the control group (Figure 4B). However,
CAE treatment signiﬁcantly (P < 0.05) increased the expressionlevels of hepatic Nrf2 related proteins, especially NQO1 and
UGT whose expression levels were signiﬁcantly (P < 0.05)
increased by CAE treatment in a dose-dependent manner.
4. Discussion
Liver is self-regenerative organ with highly replicative hepa-
tocytes [15]. Cholestatic liver injury is caused by disrupted bile
secretion from liver to duodenum. Stagnant bile acid and bile
salt could not convert to bile acid molecule or extract lipids
from hepatocytes into bile ﬂuid in the gut. The role of bile acid
in the liver and intestine has been well established. Its main
role is enterohepatic circulation in cholesterol metabolism, such
as eliminating cholesterol through fecal route [16,17]. Therefore,
abnormal concentrations of bile compounds are toxic to hepatic
and biliary.
Cholestasis causes cellular damage, subsequently causing
inﬂammation and ﬁbrogenesis in the liver [6]. Cholestasis can be
Seol-Wa Lim et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(12): 1158–1164 1163classiﬁed as intra-hepatic and extra-hepatic. Chronic cholestatic
liver injury is mostly intra-hepatic. It affects intra- and extra-
hepatic bile ducts. Impairment of bile formation of bile ﬂow
can cause primary biliary cirrhosis, which is a chronic inﬂam-
matory intra-hepatic liver disorder. When these ducts are
extended, intracellularly they cause hepatocyte cholestasis,
extracellularly they cause bile acid malabsorption in the colon,
thus disturbing bile acid metabolism [10,18].
Our previous studies have found that an ethanol extract of
Citrus aurantium peel contains polymethoxy ﬂavones with
potent hepatoprotective effects against binge alcohol and carbon
tetrachloride induced liver injury [11,12]. CAE treatment can
regulate the oxidative status and lipid peroxidation with
cytoprotective signals in pathologic hepatic injuries and
intoxication. We investigated the potential protective effects of
CAE (containing approximately 27% of nobiletin) against liver
injury induced by obstructive cholestasis in BDL administrated
mice. Bile duct ligation in rodents has been well established.
BDL can induce high yields of stereotypical cirrhosis,
ﬁbrogenesis, and cholestasis with morphological and
biochemical changes of liver and serum comparable to human
hypercholesterolemia [5,19]. Our results demonstrated that the
progression of liver ﬁbrosis and cholestasis in mice underwent
BDL for 4 weeks was attenuated by CAE.
Serum concentrations of ALT, AST, GGT, TCHO, and TBIL
are known to increase during the development of cholestatic
liver injury in mice with BDL. Oral administration of CAE
markedly reduced the levels of these hepatic enzymes, the major
biomarkers of hepatic injury. GGT is the highest in case of intra-
or post-hepatic biliary obstruction in all forms of liver disease
[20]. Elevated serum GGT can lead to increased free radical
production and glutathione depletion, thus generating
superoxide radicals with hepatic steatosis [21–23]. Our result
demonstrated that serum markers of hepatic tissue injury were
signiﬁcantly attenuated by CAE (200 mg/kg) treatment in
BDL-induced serum hepatic enzymes. The extent of attenua-
tion by CAE was higher than that of silymarin (200 mg/kg).
Furthermore, it has been known that oxidative stress is one of
the main contributors in cholestatic liver disease [24]. During
liver cholestasis, oxidative stress occurs. In cholestasis induced
liver injury, lipid peroxidation is increased. It has been
reported that increased oxidative stress contributes to toxic bile
acid stagnant, thus stimulating reactive oxygen species [25]. In
the present study, BDL accelerated oxidative stress and lipid
peroxidation as evidenced by increased NO and TBARS
concentrations. However, oral administration with CAE
protected BDL mice against liver injury with hepatic cholestasis.
GSH and SOD are important antioxidant and detoxiﬁcation
enzymes in intracellular protective mechanisms. These en-
zymes are rapidly cleared from circulation in serum. They act
as scavengers of reactive oxygen species [26,27]. Our results
also revealed the depletion of GSH and SOD levels in BDL-
induced hepatic injury. Administration of CAE restored
serum GSH and SOD levels, indicating that CAE could pre-
vent the accumulation of free radicals in chronic liver injury
induced by BDL.
Recently, it has been reported that cholestatic liver injury can
result in inﬂammatory necrosis [28]. We also demonstrated that
serum levels of pro-inﬂammatory cytokines and apoptosis
factors were increased in BDL-induced chronic hepatic injury.
Plasma biomarkers of pro-inﬂammatory cytokines such as IL-
2, IL-4, IL-6, TNF-a, and AMPK were signiﬁcantly reducedby CAE treatment, implying that CAE has anti-inﬂammatory
activity in cholestasis. It has been reported that activation of
phospho-AMPK can inhibit pro-inﬂammatory mediators against
stress and collagen deposition in liver ﬁbrosis [29]. These results
are in agreement with previous reports that CAE treatment can
protect against alcohol and CCl4 intoxication induced hepatic
injury in a mouse model [11,12].
This study revealed that CAE + BDL mice had signiﬁcantly
lower level of FAS and Caspase-8 compared to BDL alone mice.
Hepatocytes apoptosis in obstructive cholestatic liver injury can
be induced by toxic bile salts such as glycochenodeoxycholic
acid that can induce apoptosis in mitochondria-controlled Cas-
pase-8 pathway [1]. Caspase-8 is a protease abundant in the liver.
It initiates apoptosis by FAS and tumor necrosis factor (TNF)
[30,31]. It has been reported that toxic bile salts such as
glycochenodeoxycholic acid can induce Caspase-8 activation
through direct activation of FAS, which activates cell death in
FAS receptor-dependent manner [32]. TRAIL is also a member
of the TNF family. It induces apoptosis with tumor selectivity
[33,34]. Seol et al. have reported that TRAIL-induced apoptosis
requires Caspase-8 [35]. In this study, we also demonstrated
that CAE could inhibit FAS, TNF, Caspase-8, and TRAIL.
Therefore, CAE could inhibit toxic bile salts induced
apoptosis in the liver.
To redox an oxygen radical-dependent liver pathogenesis,
speciﬁc pathway can be targeted to prevent oxidative liver injury
[36]. As previous described, toxic bile acid can lead to oxidative
stress in obstructive cholestasis. To restore redox balance,
speciﬁc pathways can be activated to protect liver from
damage, including ﬁbrosis and chronic liver injury [37,38]. In
the liver, BDL activated oxidative injury that inhibiting
regulator of cellular oxidative stress, Nrf-2, which binding to
NQO1, gGCSc, and UGT with superoxide scavenging activity
[39,40]. The highly inducible enzyme NQO1 and rate-limiting
enzyme UGT can recover their cellular redox status in oxida-
tive condition after liver damage. We found that CAE induced
the expression of antioxidant protein, suggesting that CAE
indeed can induce transcription factor Nrf2, thus triggering
antioxidant proteins.
In conclusion, this study showed that nobiletin rich extract
CAE could protect liver against inﬂammation, cholestasis, and
apoptosis induced by BDL stimulating antioxidant and anti-
apoptotic mechanisms in mice. Based on these ﬁndings, we
suggest that CAE should be avoided as therapeutic application in
clinical settings for cholestatic disorders caused by bile duct
obstruction.
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